If you are located in Europe or North America and would like to learn more about how the Clinical Bridge can help you progress your drug from discovery to market, schedule your free discovery call with PRONAV Clinical or one of our partner companies today.
Clinical Bridge: Supporting Drug Development From Discovery to Clinical Site
Clinical Bridge Partners
![FITCI_Logo_Open_Door_Transparent_COLORS[47297130].png](https://static.wixstatic.com/media/68e50b_f9d2eadb67664cd787acbf07b64f7710~mv2.png/v1/fill/w_980,h_1066,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/FITCI_Logo_Open_Door_Transparent_COLORS%5B47297130%5D.png){kind=logo}
FITCI
Maryland’s premier biotech incubator supporting startups with lab space, mentorship, and funding networks.
Court Square Group
Cloud and AI innovators providing a compliant, secure digital collaboration environment through Regdocs365.
Brilliant science deserves a clear path to the clinic – but for many early-stage biotechs, the road from discovery to Phase I trials is anything but simple. While founders and scientists understand their technical drug innovations inside and out, many early-stage companies struggle with how to get their drugs to the clinical site – for example, navigating regulations, finding the right supply chain partners, and developing audit-ready systems. The Clinical Bridge is a collaborative advisory program designed to guide emerging biotech companies through the critical transition from research to clinical readiness. We bring together five expert partners - each a leader in their field - to form a unified bridge of support spanning incubation, operations, compliance, IT, and clinical logistics.
Our mission is simple: help innovators move smarter, faster, and with greater confidence toward Phase I trials.
What the Program Offers
Operational gaps and unclear CMC or quality frameworks often delay clinical readiness, while complex GMP, data integrity, and validation requirements pose steep regulatory hurdles during the transition from the lab to clinical trials. By bringing together five specialized companies that understand the early development journey, the Clinical Bridge offers biotech founders the expertise, structure, and guidance needed to move forward with confidence.
Through Clinical Bridge, biotech founders gain access to a team of trusted advisors representing key sectors of the clinical development process. This includes specialized expertise from PRONAV Clinical, FITCI, and three additional partner companies, each focused on critical areas of bringing a new therapy to the clinical site.
Through the program, participants can access:
-
Free advisory sessions with seasoned industry professionals.
-
Strategic guidance on where to focus resources and what services to engage.
-
Tailored support to help streamline the journey from discovery to Phase I trials.
